Potential Amplification of the Myocardial Infarct Size Limiting Effects of Exenatide by Cilostazol, a Phosphodiesterase III Inihibitor

Project: Other project

StatusFinished
Effective start/end date5/10/115/31/13

Funding

  • Amylin Pharmaceuticals Incorporated: $88,457.70